Skip to main content

A fully integrated, animal-free, end-to-end modelling approach to oral drug product development

Project description

Animal-free alternatives for drug development

The demand for oral drug products is high. This poses a challenge for the pharmaceutical industry, since most drugs coming through the pharma pipeline are too poorly soluble to be efficiently absorbed from the digestive tract. To keep the pharma industry in Europe competitive, scientists must find ways to formulate poorly soluble drugs for oral use more efficiently. However, they must also adhere to Europe’s commitment to reduce the use of animals in research. With this in mind, the EU-funded InPharma project will strive towards animal-free methods to develop and test effective new oral formulations. Thirteen early-stage researchers will receive intersectoral training to acquire the professional skills necessary to revolutionise oral medication in Europe. The research will focus on harnessing computational pharmaceutics, biorelevant laboratory tests and advanced pharmacokinetic modelling.

Coordinator

UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
Net EU contribution
€ 366 245,76
Address
Western Road
T12 YN60 Cork
Ireland

See on map

Region
Ireland Southern South-East
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00

Participants (10)

FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV
Germany
Net EU contribution
€ 505 576,80
Address
Hansastrasse 27c
80686 Munchen

See on map

Region
Bayern Oberbayern München, Kreisfreie Stadt
Activity type
Research Organisations
Other funding
€ 0,00
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON
Greece
Net EU contribution
€ 243 017,64
Address
6 Christou Lada Str
10561 Athina

See on map

Region
Κεντρικός Τομέας Αθηνών Aττική Αττική
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00
SYDDANSK UNIVERSITET
Denmark
Net EU contribution
€ 446 283,00
Address
Campusvej 55
5230 Odense M

See on map

Region
Danmark Syddanmark Fyn
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00
FACHHOCHSCHULE NORDWESTSCHWEIZ
Switzerland
Net EU contribution
€ 562 553,28
Address
Bahnhofstrasse 6
5210 Windisch

See on map

Region
Schweiz/Suisse/Svizzera Nordwestschweiz Aargau
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00
ASTRAZENECA AB
Sweden
Net EU contribution
€ 140 991,48
Address
Vastra Maelarhamnen
151 85 Sodertaelje

See on map

Region
Östra Sverige Stockholm Stockholms län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00
BAYER AKTIENGESELLSCHAFT
Germany
Net EU contribution
€ 252 788,40
Address
Kaiser-wilhelm-allee 1
51373 Leverkusen

See on map

Region
Nordrhein-Westfalen Köln Leverkusen, Kreisfreie Stadt
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00
JANSSEN PHARMACEUTICA NV
Belgium
Net EU contribution
€ 384 480,00
Address
Turnhoutseweg 30
2340 Beerse

See on map

Region
Vlaams Gewest Prov. Antwerpen Arr. Turnhout
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00
F. HOFFMANN-LA ROCHE AG
Switzerland
Net EU contribution
€ 187 517,76
Address
Grenzacherstrasse 124
4070 Basel

See on map

Region
Schweiz/Suisse/Svizzera Nordwestschweiz Basel-Stadt
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00
SOLVIAS AG
Switzerland
Net EU contribution
€ 140 638,32
Address
Romerpark 2
4303 Kaiseraugst

See on map

Region
Schweiz/Suisse/Svizzera Nordwestschweiz Aargau
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00
ZENTIVA, K.S.
Czechia
Net EU contribution
€ 234 871,56
Address
U Kabelovny 130
10237 Prague

See on map

Region
Praha Hlavní město Praha
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 0,00